CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
IGRT/VMAT focal therapy boost to DILradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03030625
NCT03030625N/ACompleted

Dose Intensification With a Focal Boost to Dominant Intraprostatic Lesion Using Volumetric Modulated Arc Therapy /Image Guided Radiotherapy in Patients With Localized Prostate Cancer

Fundación de Investigación Biomédica - Hospital Universitario de La Princesa·interventional·Posted Jan 25, 2017·Updated Jul 3, 2024

In Brief

A clinical study evaluating IGRT/VMAT focal therapy boost to DIL for Prostate Cancer. Completed, enrolled 30 participants across 1 site.

Detailed Summary

The aim of this study was to determine the efficacy and safety of the implementation of a program of " image-guided focal Intensification dose to intraprostatic dominant lesion " in men with localized prostate cancer (PCa) of intermediate and high risk (criteria NCCN) eligible to receive radiotherapy in the Department of Radiation Oncology of HUP (Hospital Universitario de La Princesa), within the established dose escalation protocol with intensity modulated image-guided radiotherapy (IMRT / IGRT).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsProstate Cancer
CountriesSpain
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJan 25, 2017
Enrollment StartMar 13, 2017
Primary CompletionJan 25, 2023
TodayJul 2, 2026
Enrollment to primary: 5.9 yearsPosted 9.4 years ago

Interventions

IGRT/VMAT focal therapy boost to DILradiation

Image-guided/VMAT focal Intensification dose to intraprostatic dominant lesion in men with localized prostate cancer (PCa) of intermediate and high risk (criteria NCCN) eligible to receive radiotherapy